Statement [Line Items] | Period [Axis] |
---|
2016-01-01 - 2016-12-31 |
---|
Notes Tables | |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | | | | | | | | | | | | | | | | | | 20,000 | | | | $0.40 | | June 2016 | | Equity | 136,364 | | | | $0.66 | | February 2018 | | Equity | 6,363,638 | | | | $0.75 | | February 2018 | | Equity | 5,047,461 | | | | $0.65 | | December 2017 | | Equity | 232,964 | | | | $0.65 | | December 2017 | | Equity | 2,884,615 | | | | $0.52 | | March 2019 | | Liability | 1,474,615 | | | | $0.52 | | March 2019 | | Liability | 3,525,000 | | | | $0.52 | | June 2019 | | Liability | 1,079,137 | | | | $0.70 | | February 2020 | | Equity | 250,000 | | | | $0.70 | | February 2020 | | Equity | 25,115,384 | | | | $0.52 | | March 2021 | | Liability | 67,500,000 | | | | $0.52 | | June 2021 | | Liability | 113,629,178 | | | | | | | | | |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | Stock Options – Incentive Plans | | | | | Weighted- Average Exercise Price | | | Weighted- Average Remaining Contractual Term | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | | | | | Outstanding at January 1, 2016 | | | 11,069,166 | | | $ | 0.78 | | | | 6.1 | | | $ | - | | Granted | | | - | | | $ | - | | | | | | | $ | - | | Exercised | | | - | | | $ | - | | | | | | | $ | - | | Forfeited or expired | | | (11,069,166 | ) | | $ | 0.78 | | | | | | | $ | - | | Outstanding at May 4, 2016 | | | - | | | $ | - | | | | - | | | $ | - | | Exercisable at May 4, 2016 | | | - | | | $ | - | | | | - | | | $ | - | | Vested and expected to vest at May 4, 2016 | | | - | | | $ | - | | | | - | | | $ | - | | Stock Options – 2016 Omnibus Plan | | | | | | | | Weighted- Average Remaining Contractual Term | | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | | | | | | Outstanding at May 5, 2016 | | | - | | | $ | - | | | | - | | | | $ | - | | Granted | | | 1,370,000 | | | $ | 1.00 | | | 10.00 | | $ | - | | Exercised | | | - | | | | | | | | | | | | | | | Forfeited or expired | | | (105,000 | ) | | | | | | | | | | | $ | - | | Outstanding at December 31, 2016 | | | 1,265,000 | | | $ | 1.00 | | | 9.51 | | | | $ | - | | Exercisable at December 31, 2016 | | | 331,665 | | | $ | 1.00 | | | 9.51 | | | | $ | - | | Vested and expected to vest at December 31, 2016 | | | 1,265,000 | | | $ | 1.00 | | | | 9.51 | | | | $ | - | | |
Schedule of Stockholders' Equity Note, Warrants or Rights Issued for Services [Table Text Block] | Warrants to Service Providers | | | | | Weighted- Average Exercise Price | | | Weighted- Average Remaining Contractual Term | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | | | | | Outstanding at January 1, 2016 | | | 406,364 | | | $ | .67 | | | | 3.3 | | | $ | - | | Granted | | | - | | | $ | - | | | | | | | $ | - | | Exercised | | | - | | | $ | - | | | | | | | $ | - | | Forfeited or expired | | | (406,364 | ) | | $ | .67 | | | | | | | $ | - | | Outstanding at May 4, 2016 | | | - | | | $ | - | | | | | | | $ | - | | Exercisable at May 4, 2016 | | | - | | | $ | - | | | | | | | $ | - | | |
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $1.00 | | | | 1,265,000 | | | | 9.51 | | | $ | 1.00 | | | | 331,665 | | | | 1.00 | | |
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] | | | Period from May 5, 2016 through December 31, 2016 | | | Period from January 1, 2016 through May 4, 2016 | | | Year Ended December 31, 2015 | | | | | | | | | | | | | | | | | | | | | | | | | Sales and marketing | | $ | 8,963 | | | $ | 18,504 | | | $ | 156,297 | | Research and development | | | 9,769 | | | | 6,858 | | | | 74,989 | | General and administrative | | | 56,267 | | | | 29,719 | | | | 551,469 | | | | $ | 74,999 | | | $ | 55,081 | | | $ | 782,755 | | |